Skip to main content

Table 3 Weight reduction in T2DM patients with obesity (BMI > 25 kg/m2) (Inter group)

From: Effect of liraglutide biosimilar vs. reference liraglutide on weight reduction in T2DM patients with obesity: post hoc analysis of phase III trial

Parameter

Treatment

Week 24 (Mean ± SD)

p value

Weight

Liraglutide Biosimilar

7.3 ± 1.7

0.71

Reference Liraglutide

8.9 ± 1.7

Back to article page

Cardiovascular Diabetology – Endocrinology Reports

ISSN: 3059-4057

Contact us